Entity coverage
Gossamer Bio, Inc.
GOSS · 7 events mapped
Market Ontology has mapped 7 distinct macro, policy, and market events to GOSS. Each entry below traces the causal channel from the driver to the assumption it moved.
Recent event impacts
Full ledger →- 2026-07-02EventDilution risk from convertible notes becoming more apparent, potentially increasing share count and putting downward pressure on stock price.
- 2026-07-01EventRegulatory filing indicating a material definitive agreement. The specific nature of the agreement is unknown, but it could relate to financing, a partnership, or an acquisition, all of which are significant for a biotech company.
- 2026-07-01EventDilution risk from convertible notes; very low conversion price suggests significant potential for new shares to be issued, increasing share count.
- 2026-06-17EventDirect impact from M&A announcement. The specific terms of the agreement (e.g., acquisition price, structure) will dictate the immediate stock price reaction.
- 2026-06-17EventDebt restructuring and equity dilution. The exchange offer successfully converted a significant portion of existing convertible notes into new, higher-interest secured notes and equity. This reduces near-term debt maturities but increases future interest expense and dilutes existing shareholders.
- 2026-06-17EventDebt restructuring, dilution, and interest expense changes
- 2026-06-17EventRegulation FD disclosure often precedes or accompanies significant company news (e.g., clinical trial results, financing, strategic updates). The market will be watching for the content of this disclosure.
Continuous coverage for GOSS with alerts, structural playbooks, and options routing lives in the platform. Start a trial →